Thomas Billiet

3.8k total citations · 2 hit papers
44 papers, 3.0k citations indexed

About

Thomas Billiet is a scholar working on Genetics, Epidemiology and Immunology. According to data from OpenAlex, Thomas Billiet has authored 44 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Genetics, 23 papers in Epidemiology and 13 papers in Immunology. Recurrent topics in Thomas Billiet's work include Inflammatory Bowel Disease (27 papers), Microscopic Colitis (20 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Thomas Billiet is often cited by papers focused on Inflammatory Bowel Disease (27 papers), Microscopic Colitis (20 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Thomas Billiet collaborates with scholars based in Belgium, United States and Netherlands. Thomas Billiet's co-authors include Peter Dubruel, Sandra Van Vlierberghe, Jorg Schelfhout, Mieke Vandenhaute, Elien Gevaert, Maria Cornelissen, Thomas De Schryver, Séverine Vermeire, Marc Ferrante and Gert Van Assche and has published in prestigious journals such as Nature Communications, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Thomas Billiet

42 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A review of trends and limitations in hydrogel-rapid prototyping for tissue engineering

2012 986 citations Thomas Billiet, Peter Dubruel et al. Biomaterials profile →
The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability

2013 814 citations Thomas Billiet, Elien Gevaert et al. Biomaterials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Billiet Belgium	20	1.7k	857	772	565	469	44	3.0k
Felicity R. A. J. Rose United Kingdom	39	2.6k 1.6×	407 0.5×	121 0.2×	109 0.2×	1.6k 3.4×	125	5.1k
Kazuo Ohashi Japan	33	1.1k 0.7×	106 0.1×	860 1.1×	561 1.0×	555 1.2×	96	4.5k
Janos M. Kanczler United Kingdom	32	2.3k 1.4×	223 0.3×	145 0.2×	296 0.5×	969 2.1×	78	3.8k
Simon Young United States	26	2.3k 1.4×	142 0.2×	136 0.2×	170 0.3×	1.2k 2.6×	76	4.1k
Sandeep T. Koshy United States	22	4.4k 2.6×	631 0.7×	363 0.5×	79 0.1×	2.0k 4.3×	30	7.0k
Charles J. Doillon Canada	35	1.9k 1.1×	189 0.2×	202 0.3×	129 0.2×	1.6k 3.3×	99	4.7k
Yang Wu China	30	1.3k 0.8×	519 0.6×	67 0.1×	88 0.2×	478 1.0×	98	3.1k
Edward A. Botchwey United States	37	1.6k 1.0×	93 0.1×	151 0.2×	154 0.3×	967 2.1×	97	3.8k
Tong Cao Singapore	41	2.0k 1.2×	263 0.3×	141 0.2×	201 0.4×	912 1.9×	157	5.5k

Countries citing papers authored by Thomas Billiet

Since Specialization

Citations

This map shows the geographic impact of Thomas Billiet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Billiet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Billiet more than expected).

Fields of papers citing papers by Thomas Billiet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Billiet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Billiet. The network helps show where Thomas Billiet may publish in the future.

Co-authorship network of co-authors of Thomas Billiet

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Billiet. A scholar is included among the top collaborators of Thomas Billiet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Billiet. Thomas Billiet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bossuyt, Peter, Marc Ferrante, Anthony de Buck van Overstraeten, et al.. (2017). Risk Stratification for Surgery in Stricturing Ileal Crohn’s Disease: The BACARDI Risk Model. Journal of Crohn s and Colitis. 12(1). 32–38. 37 indexed citations

Billiet, Thomas, Isabelle Cleynen, Marc Ferrante, et al.. (2016). A variable number of tandem repeat polymorphism in the promotor region of the neonatal Fc receptor affects anti-tumour necrosis factor serum levels in inflammatory bowel disease. 10. 2 indexed citations

Bar‐Yoseph, Haggai, Matti Waterman, Ronit Almog, et al.. (2016). Prevention of Antidrug Antibody Formation to Infliximab in Crohn's Patients With Prior Failure of Thiopurines. Clinical Gastroenterology and Hepatology. 15(1). 69–75. 20 indexed citations

Billiet, Thomas, Erwin Dreesen, Isabelle Cleynen, et al.. (2016). A Genetic Variation in the Neonatal Fc-Receptor Affects Anti-TNF Drug Concentrations in Inflammatory Bowel Disease. The American Journal of Gastroenterology. 111(10). 1438–1445. 48 indexed citations

Billiet, Thomas, Isabelle Cleynen, Vera Ballet, et al.. (2015). Disease burden outweighs the impact of drug concentrations and antibodies to infliximab in primary non-response to infliximab in Crohn's disease patients. 9. 2 indexed citations

Papamichael, Konstantinos, Thomas Billiet, Marc Ferrante, et al.. (2015). Long-term outcome of IBD patients with primary non-response to anti-TNF therapy. 9. 3 indexed citations

Cleynen, Isabelle, Wouter Van Moerkercke, Thomas Billiet, et al.. (2015). Anti-TNF-induced skin manifestations in IBD patients: role for increased drug exposure?. 9. 1 indexed citations

Billiet, Thomas, Konstantinos Papamichael, Magali de Bruyn, et al.. (2015). A Matrix-based Model Predicts Primary Response to Infliximab in Crohn’s Disease. Journal of Crohn s and Colitis. 9(12). 1120–1126. 47 indexed citations

Papamichael, Konstantinos, Thomas Van Stappen, Niels Vande Casteele, et al.. (2015). Infliximab Concentration Thresholds During Induction Therapy Are Associated With Short-term Mucosal Healing in Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 14(4). 543–549. 127 indexed citations

10.

Casteele, Niels Vande, Séverine Vermeire, Anthony de Buck van Overstraeten, et al.. (2014). A Panel to Predict Long-term Outcome of Infliximab Therapy for Patients With Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 13(3). 531–538. 148 indexed citations

11.

Billiet, Thomas, Marc Ferrante, & Gert Van Assche. (2014). The Use of Prognostic Factors in Inflammatory Bowel Diseases. Current Gastroenterology Reports. 16(11). 416–416. 18 indexed citations

12.

Billiet, Thomas & Séverine Vermeire. (2014). Differences between adults and children: genetics and beyond. Expert Review of Gastroenterology & Hepatology. 9(2). 191–196. 5 indexed citations

13.

Gevaert, Elien, Laurent Dollé, Thomas Billiet, et al.. (2014). High Throughput Micro-Well Generation of Hepatocyte Micro-Aggregates for Tissue Engineering. PLoS ONE. 9(8). e105171–e105171. 42 indexed citations

14.

Vereecke, Lars, Sara Vieira‐Silva, Thomas Billiet, et al.. (2014). A20 controls intestinal homeostasis through cell-specific activities. Nature Communications. 5(1). 5103–5103. 106 indexed citations

15.

Billiet, Thomas, Björn Van Gasse, Elien Gevaert, et al.. (2013). Quantitative Contrasts in the Photopolymerization of Acrylamide and Methacrylamide‐Functionalized Gelatin Hydrogel Building Blocks. Macromolecular Bioscience. 13(11). 1531–1545. 57 indexed citations

16.

Billiet, Thomas, Elien Gevaert, Thomas De Schryver, Maria Cornelissen, & Peter Dubruel. (2013). The 3D printing of gelatin methacrylamide cell-laden tissue-engineered constructs with high cell viability. Biomaterials. 35(1). 49–62. 814 indexed citations breakdown →

17.

Billiet, Thomas, Paul Rutgeerts, Marc Ferrante, Gert Van Assche, & Séverine Vermeire. (2013). Targeting TNF-α for the treatment of inflammatory bowel disease. Expert Opinion on Biological Therapy. 14(1). 75–101. 109 indexed citations

18.

Bruyn, Magali de, Kathleen Machiels, Jennifer Vandooren, et al.. (2013). Infliximab Restores the Dysfunctional Matrix Remodeling Protein and Growth Factor Gene Expression in Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases. 20(2). 339–352. 34 indexed citations

19.

Desmet, Tim, Thomas Billiet, Ria Cornelissen, et al.. (2010). Post‐Plasma Grafting of AEMA as a Versatile Tool to Biofunctionalise Polyesters for Tissue Engineering. Macromolecular Bioscience. 10(12). 1484–1494. 37 indexed citations

20.

Billiet, Thomas. (2001). Location of the centre of resistance of the upper dentition and the nasomaxillary complex. An experimental study. European Journal of Orthodontics. 23(3). 263–273. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact